Organon & Co.
OGN News Today: Stay Updated with the Latest Organon & Co. News in Real Time
Find OGN news now at Meyka AI. Stay informed with the latest Organon & Co. stocks updates, including price news, market analysis, and expert insights.
OGN Insider Buying: Holzbaur Acquires 26K+ Shares May 08, 2026
Organon SVP Holzbaur acquires 26,448 shares at $13.35 on May 6, 2026. Two transactions filed May 7.
Organon Jumps 15% as Sun Pharma Announces $11.8B Takeover Deal
Shares of Organon surged nearly 15% on April 27, 2026, after Sun Pharmaceutical Industries announced an $11.8 billion takeover deal. The all-cash offer, priced at $14 per share, reflects a strong premium and quickly caught investor attention. Markets reacted fast, with both companies seeing sharp trading activity within hours of the news. This move marks…
Stocks in Focus Today: Sun Pharma, RIL, Axis Bank, RBL Bank, Shriram Finance, Coal India, Paytm
Indian stock markets are seeing stock-specific movement today. Global cues remain mixed, but investor focus is clearly on corporate earnings, acquisitions, and regulatory updates. We are seeing strong action in major stocks like Sun Pharma, Reliance Industries (RIL), Axis Bank, RBL Bank, Shriram Finance, Coal India, and Paytm. The overall market tone is positive, but…
Sun Pharmaceutical Industries to acquire Organon & Co. in $11.75B deal, Shares in focus
Sun Pharmaceutical Industries has made headlines with a massive global move. The company announced it will acquire Organon & Co. in a deal valued at $11.75 billion. This is one of the largest overseas acquisitions by an Indian pharma company. We see this deal as a turning point. It signals a shift from generics to…
OGN Analyst Rating Maintained at Outperform by BNP Paribas
Exane BNP Paribas maintains Organon & Co. (OGN) at Outperform with $15 per share takeover offer estimate.